久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

Invivodata
Invivodata公司對紙制病人日志的不足有著敏銳的洞察力。該公司已經支持過包括5萬名病人參與的130個臨床試驗，是獲得FDA兩項審批的唯一一家電子日志公司。但是，成為眾多電子日志公司的領頭羊很困難，目前同類供應商眾多，且都以掌上操作系統為典型產品。這家公司宣稱其收入從2004年到2005年攀升了3倍。
invivodata’s scientists defined the electronic patient reported outcomes (ePRO) industry over 20 years ago. Since that time, we have focused on developing innovative ePRO solutions for clinical research that have been used in over 250 clinical trials to collect accurate patient reported outcomes (PRO) data. Our innovations included the revolutionary DiaryPRO, the electronic patient diary and SitePRO, our site-based PRO tool. With the market’s first wireless eDiary solution, automatic patient data uploads, and our development of the space-saving invivodata? EasyCharge? connector, invivodata has evolved into the ePRO industry’s innovation-leader.

Only invivodata combines the scientific and regulatory expertise needed for ePRO with practical technology and proactive services to maximize your clinical research investment. Trial after trial, our proven ePRO systems enable sponsors to confidently determine the effectiveness of new medical products and therapies.

?